Nikolaou Anastasis
SEC CIK 1954186 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics, Inc. | 10% | 3.85M | — | $25.0K | 1 | 2023-06-15 | 2023-06-15 |
Most active insiders at ACRV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blume-Jensen Peter | Pres, CEO, Dir | $82.3K | $34.4K |
| 2 | Devroe Eric | COO | $17.2K | $1,214 |
| 3 | Levy Adam D. | CFO | $15.0K | $1,793 |
| 4 | Miller Mary | CLO | — | $1,380 |
| 5 | Gamelin Erick | Chief Development Off | — | $804.00 |
| 6 | Peterson Katharine | CAO | — | $203.01 |
| 7 | Levin Michaela | Chief Business Off | — | — |
| 8 | Palani Santhosh | Dir | — | — |
| 9 | Masson Kristina | EVP - Business Ops, Dir | — | — |
| 10 | DiRocco Derek | Dir | — | — |
Nikolaou Anastasis made no open-market trades at ACRV in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-20 | 2023-06-15 | ACRV | Acrivon Therapeutics, Inc. | Nikolaou Anastasis | 10% | S - Sale | $12.14 | -2,056 | 3.85M | -0.1% | -$25.0K |
Purchase Sale Sale after option exercise All abbreviations